Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Amyotrophic Lateral Sclerosis M114T PFN1 Mutation Deregulates Alternative Autophagy Pathways and Mitochondrial Homeostasis. | Int J Mol Sci | 2022 | 35628504 | PubTator, text mining | PubMed |
| The DEAD-Box Protein Rok1 Coordinates Ribosomal RNA Processing in Association with Rrp5 in Drosophila. | Int J Mol Sci | 2022 | 35628496 | PubTator, text mining | PubMed |
| Genomics and Immunomics in the Treatment of Urothelial Carcinoma. | Curr Oncol | 2022 | 35621673 | PubTator, text mining | PubMed |
| RNase H2, mutated in Aicardi-Goutières syndrome, resolves co-transcriptional R-loops to prevent DNA breaks and inflammation. | Nat Commun | 2022 | 35618715 | PubTator, text mining | PubMed |
| Investigating the Molecular Mechanism of Quercetin Protecting against Podocyte Injury to Attenuate Diabetic Nephropathy through Network Pharmacology, MicroarrayData Analysis, and Molecular Docking. | Evid Based Complement Alternat Med | 2022 | 35615688 | PubTator, text mining | PubMed |
| Reconsidering the Chemical Nature of Strand Breaks Derived from Abasic Sites in Cellular DNA: Evidence for 3'-Glutathionylation. | J Am Chem Soc | 2022 | 35612610 | PubTator, text mining | PubMed |
FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy. | Clin Transl Med | 2022 | 35604033 | PubTator, text mining | PubMed |
| Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial. | Sci Rep | 2022 | 35595817 | PubTator, text mining | PubMed |
| Myeloid cell-specific topoisomerase 1 inhibition using DNA origami mitigates neuroinflammation. | EMBO Rep | 2022 | 35593064 | PubTator, text mining | PubMed |
| A Universal Detection Method for Adversarial Examples and Fake Images. | Sensors (Basel) | 2022 | 35591134 | PubTator, text mining | PubMed |
| Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL. | Clin Cancer Res | 2022 | 35583604 | PubTator, text mining | PubMed |
| Non-enzymatic function of WRN RECQL helicase regulates removal of topoisomerase-I-DNA covalent complexes and triggers NF-κB signaling in cancer. | Aging Cell | 2022 | 35582959 | PubTator, text mining | PubMed |
| Noncoding RNAs related to the hedgehog pathway in cancer: clinical implications and future perspectives. | Mol Cancer | 2022 | 35581586 | PubTator, text mining | PubMed |
| DNA Damage, Defective DNA Repair, and Neurodegeneration in Amyotrophic Lateral Sclerosis. | Front Aging Neurosci | 2022 | 35572138 | PubTator, text mining | PubMed |
| Copy Number Alterations as Novel Biomarkers and Therapeutic Targets in Colorectal Cancer. | Cancers (Basel) | 2022 | 35565354 | PubTator, text mining | PubMed |
| Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward. | Cancers (Basel) | 2022 | 35565259 | PubTator, text mining | PubMed |
| New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization. | J Enzyme Inhib Med Chem | 2022 | 35548854 | PubTator, text mining | PubMed |
| Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance. | Int J Biol Sci | 2022 | 35541919 | PubTator, text mining | PubMed |
| Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer. | Ann Transl Med | 2022 | 35530962 | PubTator, text mining | PubMed |
| Comprehensive Molecular Profiling of Colorectal Cancer With Situs Inversus Totalis by Next-Generation Sequencing. | Front Oncol | 2022 | 35530355 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=52